Specific inhibition of T lymphocyte coactivation by triggering integrin β1 reveals convergence of β1, β2, and β7 signaling pathways

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 700-706

  Woodside, Darren G ^a   League, T Kent ^a   McIntyre, Bradley W ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; HERMES ANTIGEN; INTEGRIN; MONOCLONAL ANTIBODY; OKT 3;

ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; ANTIGENS, CD18; ANTIGENS, CD29; BINDING, COMPETITIVE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; HUMANS; INTEGRIN ALPHA4; INTEGRIN BETA CHAINS; INTEGRINS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0029960570     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Bretscher, P., and M. Cohn. 1979. A theory of self-nonself discrimination. Science 169:1042.
2. Meuller, D. L., M. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
3. D'ambrosio, D., K. L. Hippen, S. A. Minskoff, I. Mellam, G. Pani, S. A. Siminovitch, and J. C. Cambier. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science 268:293.
4. Doody, G. M., L. B. Justement, C. C. Delibrias, R. J. Matthews, J. Lin, M. L. Thomas, and D. T. Fearon. 1995. A role in B cell activation of CD22 and the protein tyrosine phosphatase SHP. Science 269:242.
5. Moretta, A., M. Viale, C. Bottino, A. M. Orengo, L. Morelli, R. Augugliaro, E. Barbaresi, E. Ciccone, and L. Moretta. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178:597.
6. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1994. NKB1: an NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180:537.
7. Moretta, A., M. Viale, S. Sivori, G. Bottino, L. Morelli, R. Augugliaro, M. Barbaresi, D. Pende, E. Ciccone, M. Lopez-Botet, and L. Moretta. 1994. Human NK cell receptors for HLA-class I molecules: evidence that the Kp43 (CD94) molecule functions as a receptor for HLA-B alleles. J. Exp. Med. 180: 454.
8. Phillips, J. H., J. E. Gumperz, P. Parham, and L. L. Lanier. 1995. Superantigen-dependent cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403.
9. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, J. M. Freeman, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
10. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
11. Burkly, L. C., A. Jakubowski, B. M. Newman, M. D. Rosa, G. Chirossa, and R. R. Lobb. 1991. Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation. Eur. J. Immunol. 21:2871.
12. + T lymphocytes. Proc. Natl. Acad. Sci. USA 88:6403.
13. + T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J. Immunol. 145:59.
14. Matsuyama, T., A. Yamada, J. Kay, K. M. Yamada, S. K. Akiyama, S. F. Schlossman, and C. Morimoto. 1989. Activation of CD4 cells by fibronectin and anti-CD3 antibody: a synergistic effect mediated by the VLA-5 fibronectin receptor complex. J. Exp. Med. 170:1133.
15. Davis, L. S., N. Oppenheimer-Marks, J. L. Bednarczyk, B. W. McIntyre, and P. E. Lipsky. 1990. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J. Immunol. 145:785.
16. Van Seventer, G. A., Y. Shimizu, K. J. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579.
17. 7 co-stimulation of human peripheral blood T cell proliferation. Cell Adhesion Commun. 2:539.
18. Bednarczyk, J. L., T. K. Teague, J. N. Wygant, L. S. Davis, P. E. Lipsky, and B. W. McIntyre. 1992. Regulation of T cell proliferation by anti-CD49d and anti-CD29 monoclonal antibodies. J. Leukocyte Biol. 52:456.
19. + lymphocytes. Nature 339:152.
20. 1 functions as a receptor for tenascin, fibronectin, and vitronectin. J. Biol. Chem. 39:23196.
21. Ruegg, C. R., R. Chiquet-Ehrismann, and S. S. Alkan. 1989. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc. Natl. Acad. Sci. USA 86:7437.
22. Hemesath, T. J., L. S. Marton, and K. Stefansson. 1994. Inhibition of T cell activation by the extracellular matrix protein tenascin. J. Immunol. 152:5199.
23. Ticchioni, M., C. Aussel, J-P. Breittmayer, S. Manie, C. Pelassy, and A. Bernard. 1993. Suppressive effect of T cell proliferation via the CD29 molecule: the CD29 mAb 1 "K20" decreases diacylglycerol and phosphatidic acid levels in activated T cells. J. Immunol. 151:119.
24. 1 will prevent but not terminate proliferation of human T cells. Cell Adhesion Commun. 2:169.
25. Bednarczyk, J. L., S. M. Carroll, C. Marin, and B. W. McIntyre. 1991. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation. J. Cell. Biochem. 46:206.
26. Champe, M., B. W. McIntyre, and P. W. Berman. 1995. Monoclonal antibodies that block the activity of leukocyte function-associated antigen 1 recognize three discrete epitopes in the inserted domain of CD11a. J. Biol. Chem. 270:1388.
27. 1. J. Biol. Chem. 267:25274.
28. 4 subunit cDNA. J. Cell. Biochem. 51:465.
29. 1, heterodimer involved in the regulation of cell adhesion. J. Biol. Chem. 269:8348.
30. Edwards, C. P., M. Champe, T. Gonalez, M. E. Wessinger, S. A. Spencer, L. G. Presta, P. W. Berman, and S. C. Bodary. 1995. Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1). J. Biol. Chem. 270:12635.
31. + memory T cells with hallmarks of gut-tropism. J. Immunol. 151:717.
32. McIntyre, B. W., E. L. Evans, and J. L. Bednarczyk. 1989. Lymphocyte surface antigen L25 is a member of the integrin receptor superfamily. J. Biol. Chem. 264:13745.
33. + dentritic epidermal cell lines. J. Leukocyte Biol. 43:502.
34. Umetsu, D. T., D. Katzen, T. Chatila, R. Miller, H. H. Jabara, M. Maher, H. Oettgen, C. Terhorst, and R. F. Geha. 1987. Requirements for activation of human peripheral blood T cells by mouse monoclonal antibodies to CD3. Clin. Immunol. Immunopathol. 43:48.
35. Williams, J. M., D. Deloria, J. A. Hansen, C. A. Dinarello, R. Loerscher, H. M. Shapiro, and T. B. Strom. 1985. The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin-1. J. Immunol. 135:2249.
36. Geppert, T. D., and P. E. Lipsky. 1988. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3: regulatory influences of monoclonal antibodies to additional T cell surface determinants. J. Clin. Invest. 81:1497.
37. Hara, T., S. M. Fu, and J. L. Hansen. 1985. Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J. Exp. Med. 161:1513.
38. Shimizu, Y., G. A. Van Seventer, R. Siraganion, L. Wahl, and S. Shaw. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143:2457.
39. Oravecz, T., E. Monostori, E. Kurucz, L. Takacs, and I. Ando. 1991. CD3-induced T cell proliferation and interleukin-2 secretion is modulated by the CD45 antigen. Scand. J. Immunol. 34:531.
40. Udagawa, T., and B. W. McIntyre. 1992. A VLA-4 α-chain specific monoclonal antibody enhances CD3-induced IL-2/IL-2 receptor-dependent T-cell proliferation. Lymphokine Cytokine Res. 11:193.
41. Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233.
42. Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786.
43. 1 integrins. Cell. Immunol. 161:8.
44. Sato, T., K. Tachibana, Y. Nojima, N. D'avirro, and C. Morimoto. 1995. Role of the VLA-4 molecule in T cell costimulation: identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4. J. Immunol. 155:2938.
45. Sastry, S. K., and A. F. Horwitz. 1993. Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling. Curr. Opin. Cell Biol. 5:819.
46. Hibbs, M. L., S. Jakes, S. A. Stacker, R. W. Wallace, and T. S. Springer. 1991. The cytoplasmic domain of the integrin lymphocyte function-associated antigen 1 β subunit: sites required for binding to intercellular adhesion molecule 1 and the phorbol ester-stimulated phosphorylation site. J. Exp. Med. 174:1227.
47. 2 (LFA-1, CD11a/CD18) cytoplasmic domain/cytoskeleton interaction. J. Exp. Med. 181:315.
48. 2 are involved in endoplasmic reticulum retention, dimerization, and cytoskeletal association. J. Immunol. 155: 1252.
49. Yamada, A., Y. Nojima, K. Sugita, N. H. Dang, S. F. Schlossman, and C. Morimoto. 1991. Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system. Eur. J. Immunol. 21:319.
50. Bryan, R. G., L. Yongqin, K. R. Totten, M. Van, T. Tan, and R. R. Rich. 1994. Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes. Cell. Immunol. 157:158.
51. 2+ levels. J. Immunol. 149:3872.
52. Chen, D., and E. Rothenberg. 1994. Interleukin-2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179:931.
53. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy: role of T cell actin cytoskeleton. J. Exp. Med. 181:577.
54. Pardi, R., L. Inverardi, C. Rugarli, and J. R. Bender. 1992. Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/CD18-cytoskeleton association in T lymphocytes. J. Cell Biol. 116:1211.
55. Poo, H., B. Fox, and H. R. Petty. 1994. Ligation of CD3 triggers transmembrane proximity between LFA-1 and cortical microfilaments in a cytotoxic T cell clone derived from tumor infiltrating lymphocytes: a quantitative resonance energy transfer microscopy study. J. Cell. Physiol. 159:176.
56. Miyamoto, S., S. K. Akiyama, and K. Yamada. 1995. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267:883.